Catalog Number 42055120-080 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Pain (1994); Stenosis (2263)
|
Event Date 11/21/2023 |
Event Type
Injury
|
Event Description
|
It was reported that two supera stents (5.5x120 mm and 5.5x80 mm) were implanted on (b)(6), 2023.On (b)(6), 2023, the patient presented with severe claudication of the right leg and an angiogram confirmed a stent re-stenosis had occurred.No treatment has been provided at this time.No additional information was provided.
|
|
Manufacturer Narrative
|
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
|
|
Manufacturer Narrative
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect(s) of stenosis and pain is listed in the supera peripheral stent systems instructions for use as a known patient effect(s) of coronary procedures.A cine was received and reviewed by an abbott vascular clinical specialist: the radiographic images provided do show the reported occlusion in what appears to be the distal section of the previously deployed supera located in the distal superficial femoral artery (sfa).A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.B3 - date of event updated from 3/24/2023 to 11/21/2023.
|
|
Event Description
|
Subsequently to the initial filed emdr reported additional information was received:
it was reported that both supera stents were implanted in the femoral popliteal artery.No additional information was provided.
|
|
Search Alerts/Recalls
|